Riskpilot← Back to searchSign inGet full accessNITELVA HELSESENTER AS
ASActiveOrg 913951921Dampsagveien 25, 2004 LillestrømGeneral medical practice activities · NACE 8621Est. 20145 employees
Revenue 2024
NOK 5,5M
-1% vs 2023
EBITDA margin
6.8%
-66% vs 2023
Equity ratio
-99.3%
Financial strength
Net profit 2024
NOK 164K
-80% vs 2023
| Revenue | NOK 5,5M | -1% |
| EBITDA | NOK 373K | -66% |
| Net profit | NOK 164K | -80% |
| Total assets | NOK 2,8M | -12% |
| Equity | NOK -2,8M | +6% |
| Employees | 5 | — |
Legal name
NITELVA HELSESENTER AS
Org number
913951921
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
11. august 2014
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Drift av helsesenter der den medisinske behandlingen er av høy faglig og etisk standard. Videre tilby lokaler for ulike profesjoner innen helsesektoren. Kursvirksomhet/medisinsk faglig veiledning. Klinisk forskning/kliniske studier.
Address
Dampsagveien 25, 2004 Lillestrøm
Phone
+4767211222
Email
post@nitelvahelsesenter.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 816 | 4 771 | 5 759 | 5 544 | 5 494 |
| Staff expenses | −1 423 | −1 411 | −1 936 | −2 737 | −2 984 |
| EBITDA | 277 | 672 | 225 | 1 086 | 373 |
| Depreciation & amort. | −241 | −313 | −313 | −270 | −225 |
| EBIT | 37 | 359 | −88 | 815 | 148 |
| Net financials | −0 | 0 | −0 | 7 | 16 |
| Profit before tax | 37 | 359 | −88 | 822 | 164 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 37 | 359 | −88 | 822 | 164 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 599 | 1 434 | 2 116 | 3 159 | 2 778 |
| Equity | −4 349 | −4 051 | −4 137 | −2 923 | −2 759 |
| Long-term debt | 5 617 | 4 323 | 4 640 | 4 313 | 3 355 |
| Short-term debt | 1 331 | 1 161 | 1 613 | 1 769 | 2 181 |
| Total debt | 6 949 | 5 485 | 6 253 | 6 082 | 5 537 |
EBITDA margin
6.8%
This company
15.8%
Market median
-57% vs market
20202024
Equity ratio
-99.3%
This company
38.2%
Market median
-360% vs market
20202024
Return on equity
16402100.0%
This company
18.4%
Market median
+89141748% vs market
20202024
Net profit margin
3.0%
This company
8.1%
Market median
-63% vs market
20202024
Asset turnover
1.98×
This company
1.12×
Market median
+77% vs market
20202024
Debt / equity
2.01×
This company
0.62×
Market median
-224% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JH Chief Executive Officer | Chief Executive Officer | 2014 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2019 | |
| Chairman | 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 80% | 80% | 2022 | |
| Company | 20% | 20% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nitelva Invest As
NITELVA HELSESENTER AS Board members of NITELVA HELSESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jørgen Hans Edvard Høydahl | Chief Executive Officer | 0 companies |
| Silje Helene Waaler Aslaksen | Board of Directors | 0 companies |
| Kristin Undheim | Chairman | 0 companies |